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Introduction

Glycated haemoglobin
) is an important marker for long-term assessment of glycemic state in patients with diabetes. Glycation is the non-enzymatic addition of a sugar residue to amino groups of proteins. Numerous proteins in the body are glycated, but glycated haemoglobin (GHb) in blood is the analyte clinically most widely used to monitor the glycemic control of the individual. The concentration of GHb is directly proportional to the mean concentration of glucose in the blood and the lifespan of erythrocytes (up to 120 days). Thus, the GHb concentration represents an integrated value for glucose over the preceding 2-3 months. GHb provides an index of glycemic control that is free of the wide diurnal glucose fluctuations and is unaffected by recent exercise or food ingestion [1] .
Non-enzymatic protein glycation plays a role in the evaluation of metabolic control and in our understanding of the pathogenic mechanisms of chronic complications, as well as the relationship between metabolic equilibrium and the development of diabetes. Measurement of early glycation products has shown itself to be a valuable instrument in the metabolic monitoring of diabetic patients. The possibility to monitor some intermediate and advanced glycation end-products will certainly provide important information on the pathogenesis and progression of chronic complications, and it will be useful in verifying the effectiveness of glycating substances and antioxidants in diabetes [2] . Most methods of the HbA 1C determination are certified for traceability to the Diabetes Control and Complication Trial (DCCT) designated comparison method, which originally was a high-performance liquid chromatography (HPLC) method (Bio-Rex 70, Bio-Rad) [3] . In the US, an HPLC method was introduced as the specified comparison method for the US National Glycohemoglobin Standardization Program (NGSP) [4] . [5, 6] . In a first step, haemoglobin is cleaved into peptides by the enzyme endoproteinase and in a second step, the obtained glycated and non-glycated N-terminal hexapeptides are separated and quantified by HPLC with electrospray ionisation MS detector or in a two-dimensional approach using HPLC and capillary electrophoresis with UVdetection. Both principles give identical results. HbA 1c is measured as the ratio between the glycated and non-glycated hexapeptides; calibrators consisting of mixtures of highly purified HbA 1c and HbA 0 are used for this purpose [7] . Unfortunately, this new IFCC reference system gives the HbA 1c values by 1 to 2% lower compared to the DCCT results for the persons with type 2 Diabetes Mellitus. The reason is the lack of specificity of the original BioRex 70 HbA 1c assay [8] .
Central European Journal of Chemistry
Although NGSP harmonization [9, 10] has improved HbA 1c standardization along the preceding time, the newly established IFCC program, which is scientifically superior in concept and system, has been available. It should replace the DCCT methods in the near future with consensus and agreement from all related healthcare teams to take the full advantages of this new reference system.
The relationship of NGSP with IFCC method is described by the following Master Equation Theoretical slope in method comparison should be equal to 1, therefore a proportional systematic error is indicated when a significant difference between the observed and theoretical values is found. Similarly, a significant difference between the observed and theoretical intercepts is an indication of a constant systematic error. Therefore, it is reasonable to consider alternatives to ordinary least-squares regression analysis for assessment of the methods comparison.
Weighted least-squares regression (WLS) allows for using a non-constant standard deviation for the investigated method (Y), but it is still presumed that the reference method (X) is without random measurement errors. Weights are introduced that are inversely proportional to the squared standard deviation of Y measurements at a given concentration.
The Deming regression (DR) permits random (measurement) errors of both compared methods requiring that the ratio between their standard deviations is known. The DR is primarily used when the standard deviations are constant. The residuals between the observed and regression points are considered along the line not parallel to Y axis but located at an angle determined by the ratio λ of the variances of the compared methods λ = s X 2 / s Y 2 . Then, as is obvious in the least squares method, the sum of squared deviations between the observed and calculated values is minimized. A weighted modification of the DR takes into account non-constant measurement errors for both methods. Nevertheless, it still has to be presumed that the ratio between the variances (or standard deviations) of the methods is constant. This is true mainly for the common situation when standard deviations are proportional to concentration (constant relative standard deviations or coefficients of variation) for both methods [14] . A special case of DR is orthogonal regression (OR), where it is assumed that the ratio λ = 1 so that the effect of random errors on both variables is equal. In this case the above mentioned angle is 45° and the perpendicular direction of residuals to regression line is considered.
In addition to the above mentioned parametric regression alternatives (fulfilling assumptions about the errors distribution), several non-parametric versions of linear regression were established in the method comparison studies, of which the Passing-Bablok regression (PB) is probably the most widely used variant [15] [16] [17] . PB is based on the rank principle and is claimed insensitive to outliers so that considering this aspect it is better than its parametric counterparts.
Experimental Procedure
Investigated patient samples
Collection of the blood samples was performed in a standard way. In sampling, 3 mL of whole blood was collected in the evacuated VACUETTE® blood collection tubes available with interior coated spray-dried K 3 EDTA (tripotassium ethylenediammine-tetraacetic acid). The K 3 EDTA additives (Greiner Bio One International AG) inhibit the coagulation of the blood specimen by binding Ca 2+ , thus preserving the blood cells for the test analyses up to 24 hours. The samples were shipped to the medical laboratory in a portable refrigerator and stored 1-2 h at +2 to +8 º C until they were analyzed. Prior the analysis the whole blood samples were brought to the room temperature and mixed by inverting 2-3 minutes on a rotator. Haemolyzate was prepared by mixing of 10 µL of the EDTA blood specimen with 1000 µL of haemolysing reagent.
The medical laboratory providing the laboratory testing has been accredited according to the ISO 17025 and strictly followed particular requirements for quality and competence. The personnel of medical laboratory were bound by the common ethical codes of their respective profession. The laboratory results utilized in the present study were used for the regular control and monitoring of the diabetes status of the patients. The patients have been clearly aware of the purpose for which the information was collected. They were properly informed by the diabetologist about the importance of the laboratory testing of their glycated haemoglobin A 1c and that it is an indispensable part of the monitoring of their diabetic status.
HbA 1c measurement
The HbA 1c determination method is based on turbidimetric inhibition immunoassay (TINA) of the haemolysed whole blood samples. The test system uses a latexenhanced competitive turbidimetric immunoassay for determining glycated haemoglobin A 1c in the hemolyzate with a spectrophotometric assessment of total Hb by an automated analysis using an automatic clinical chemistry analyser. The automated measurement takes 10 minutes for the first result with the subsequent results at nine-second intervals.
Two automatic analyzers were used, Advia and Hitachi. Chemistry Systems Bayer (Advia 1200) provided the NGSP-calibrated assay. On the other hand, Roche Diagnostic Systems (Hitachi 912) was calibrated according to the IFCC reference method. The HbA 1c values were determined using both methods.
The data set of 53 patient samples was used, 27 men from 27 to 82 years, and 26 women from 31 to 78 years. All patients were medically treated with respect to Diabetes Mellitus 2. The HbA 1c determinations and statistical assessment were performed for all regardless gender.
Since it is important to know the effect of repeatability, additional measurements were intentionally added so that for ten patient samples 6-8 replicates were made; other measurements were made in duplicates. Based on the obtained small standard deviation values, it can be stated that the repeatability of the sample processing has negligible impact on the final results [18]. 
Method comparison
Results and Discussion
The values of the mean and the standard deviation (SD) of all HbA 1c determination were 8.32% ± 1.98% and 8.32% ± 2.13%, from Hitachi and Advia, respectively, for 53 patient samples. Comparison of both methods was performed using the regression techniques, which in respect to the fact that neither of the methods is errorfree; further applied methods were OLS and WLS -just for comparison. In addition, several kinds of software, nowadays common mainly for clinical chemists, were utilized in order to give a suitable overview on the regression techniques as well as the practical ways of calculations.
The results summarized in Table 1 show that the relationship between the NGSP and the non-derived IFCC reference method (not recalculated to NGSP) is linear, the slope is not deviated significantly from 1, whereas the intercept is significantly different from 0, dependent whether the theoretical value is or is not inside the corresponding reliability interval (b 1L , b 1U ) and (b 0L , b 0U ), respectively. This result was expectable because the IFCC reference method provides lower values than the NGSP one [11] .
Considering the data recalculated to the NGSP reference system, the comparison of IFCC-derived NGSP and NGSP HbA 1c values obtained by the Master Equation 1 shows (Table 2) that the slope is significantly different from 1 whereas the intercept is not significantly different from 0. It is justified by the utilization of the Master Equation, which adjusts the difference between the two reference methods but deflects the straight-line in the way that the differences are pronounced particularly for higher HbA 1c values. In other words, the shift of about 2% between the compared methods has been corrected (consequently, the zero intercept was achieved) but at the expense of non-theoretical slope (significantly lower than 1), as shown also on Fig. 1 .
In general, the Master Equation works quite well at relatively lower concentrations of glycated haemoglobin but, at least for the examined data, it is imprecise at high concentrations. It is not in conflict with the statement of Geistanger et al. [6] that the Master equation is a practical tool for conversion from IFCC to NGSP, since it basically improves the fit of the IFCC and NGSP results but, as mentioned above, our results show that for a perfect conversion with only negligible deviations between the methods a more limited range of the HbA 1c concentrations would be desirable.
Two measurements with the highest observed values in Fig. 1 are influential, but they confirm well the regression results originating from all other regression points. It is worth mentioning that all regression points in Fig. 1 are inside the regression confidence band where the "true" regression straight-line is expected with a 95% probability even though it is not inevitable (these points should be inside of much broader the prediction confidence band constructed for one future observation).
When the Roche Equation 2 is used the slope is also significantly different from 1, and the intercept is significantly different from 0 (Table 3) , as well. Due to both inconsistencies it may be stated that the use of Roche Equation is clearly less advisable than the Master Equation.
All above-mentioned results were deduced from the outputs of all four regression methods assuming the random errors of both compared variables. Nevertheless, a close inspection of these outputs reveals some further interesting details. Deming regression and orthogonal regression provide almost equivalent results. A very good agreement between DR and OR is caused by the DR lambda values not too different from 1. Another couple providing similar results is weighted Deming regression and Passing-Bablok method, the results of which are also not too far from the DR and OR methods. Due to a relatively good agreement between Passing-Bablok method and remaining three techniques it may be also stated that there are no outliers in the investigated data sets otherwise the results of the robust PB method would be significantly different.
The residual plot depicted in Fig. 2 indicates (by the typical < shape of residuals) the non-constant standard deviation of the methods (heteroscedasticity) therefore the results of weighted Deming regression and Passing-Bablok regression are preferred. Applied WDR technique assumes heteroscedasticity supposing the standard deviation proportional to the magnitude of the variable [22] . On the other hand, Passing-Bablok regression is robust and independent of the symmetry of the distribution of errors.
It was reported in literature that it is possible to monitor and qualify the treatment of diabetes in patients according to their HbA 1c levels. Control of Diabetes Mellitus 2 is classified as good if the NGSP HbA 1c values are < 6.5%, acceptable if HbA 1c is 6.5-7.5% and poor if HbA 1c is > 7.5% [23] . According to IDF (International Diabetes Federation), the IFCC HbA 1c levels < 4% are good, the levels in the range 4-6% are considered as satisfactory, above 6% as unsatisfactory [24] . Taking both reference systems into account we have categorized 53 investigated patients into three classes according to the HbA 1c levels indicated above and determined mutual 
Conclusions
Correct statistical comparison of two assays for determination of glycated haemoglobin HbA 1c confirmed that the NGSP reference system gives systematically higher results than the IFCC reference system since the intercept of the regression straight-line is significantly different from 0. When the recalculation of the IFCC into NGSP values is made via Master Equation, the intercept is corrected to zero so that the differences between these two reference systems are adjusted, but the resulting straight-line deviates and the slope gets worse and is significantly different from the expected value of 1. The application of Roche Equation was even less successful. All four used advanced regression techniques (respecting that both compared variables are loaded by random errors) provide similar results but considering heteroscedasticity of variables the application of the weighted Deming regression or Passing-Bablok method is preferred.
Two ways how to achieve notable improvement in comparison of the glycated haemoglobin reference systems may be considered: (1) better harmonisation of the NGSP and IFCC results, which should be ensured by regression comparison of the methods similar to that indicated by Table 1 but based on a large number of reliable measurements, (2) utilization of critical values better fitted to three categories expressing the levels of Diabetes Control.
This work aimed to provide basic information about the correct ways of comparing two laboratory methods, available statistical tools, and software. This problem is quite well known in clinical chemistry, but it is usually not properly treated by other chemists. The solved problem of the determination of glycated haemoglobin serves as a good practical example demonstrating disagreement of two compared methods and is also an excellent model showing how to solve the method harmonization. Stöckl et al. [26] demonstrated that in real life the reliability of data might be more important than the particular regression procedure applied. Nevertheless, a detailed regression study by means of several advanced regression techniques enables to find some details hidden in ordinary linear least squares regression. For example, the results shown in Table 3 are the same in all regression techniques, but the intercepts in Table 2 are different (and better) for the advanced regression techniques compared to ordinary regression. Moreover, a good accordance between Passing-Bablok and any other advance regression technique is a proof of the non-existence of gross errors and the similarity of the results achieved by the weighted and ordinary version of Deming regression indicates that the change of standard deviation with the signal value is not critical. Therefore, the best recipe is working with reliable data and appropriate regression method. 
